Oliyai Consulting Corporation (OCC) is a premier consulting firm serving the pharmaceutical and biotech industries, distinguished by the real-world expertise of its subject matter experts. We support 90 plus diverse organizations—from large pharma and biotech to startups and law firms. We accelerate drug development from lead optimization through commercialization, with a core focus on Chemistry, Manufacturing, and Controls (CMC). Leveraging deep regulatory and clinical insight, we deliver cost-effective, tailored solutions to complex scientific, technical, and operational challenges.
With a team of over 100 seasoned professionals, each with extensive experience in drug development, manufacturing, and commercialization, we offer unparalleled support to our clients. Each team member is carefully selected to ensure we deliver the highest standard of service. Our fully coordinated teams have vast connections to the global CRO/CDMO network.
Our expertise spans a variety of modalities, including small molecules, peptides, biologics, ADCs, cell therapies, and drug-device combination products. We bring deep expertise to a range of drug delivery routes, including oral, injectable (IV, SC, LAI), intravitreal, and inhalation, with specialized proficiency in pediatric formulations. We also provide phase-appropriate and tailored quality and compliance support. Beyond CMC, our capabilities encompass medicinal chemistry, toxicology, ADME/PK, clinical pharmacology, regulatory strategy, due diligence, and patent litigation support.
Founded by Dr. Reza Oliyai, a pharmaceutical executive with over 30 years of industry leadership, OCC is built on a legacy of excellence. Dr. Oliyai served as Senior VP at Gilead Sciences, where he oversaw the development of more than 200 drug candidates and brought 27 products to market. His strategic oversight and hands-on leadership provide the critical guidance that projects require to navigate complexities and succeed.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Atherton, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Drug Development, Operations, Business Strategy, Routes of Delivery, Drug Delivery Systems, Pediatric Dosage Forms, Inhalable Products, Small Molecules, Cell Therapy, Drug Device Combinations, Due diligence, Intellectual Property Assessment and Patent Litigations, Governance Optimization, Talent Assessment, Organizational Development, Biologics, Anti-Drug conjugates, Standard Dosage Forms, Long-Acting Injectables, Enabled Drug Delivery Systems, Contract Negotiations, Supply Chain Design, Quality and Compliance, Project Management, Selection of Contract Research Organizations CROs and Contract Development and Manufacturing Organizations CDMOs, CDMO Selection and Management, CMC, GMP.
- HQ
- Atherton
Oliyai Consulting Questions
Oliyai Consulting's LinkedIn profile is https://www.linkedin.com/company/oliyai-consulting
Oliyai Consulting has
11 employees.
View email and phone details for 11
employees at Oliyai Consulting.
Oliyai Consulting's industry is
Biotechnology Research
Oliyai Consulting's top competitors are
Lilac Therapeutics,
Gilead Sciences,
Elfgren Consulting,
Cytokinetics,
Summit Therapeutics, Inc.,
Helipharm Consulting Llc,
Datacompass,
Sarepta Therapeutics,
Oric Pharmaceuticals Inc.,
Pars Equality Center.
Oliyai Consulting's categories are Biotechnology Research
Oliyai Consulting's founding year is 2022
